Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series.
Saved in:
| Title: | Panitumumab can safely and effectively be substituted for cetuximab in the treatment of BRAF V600Emut metastatic colorectal cancer (mCRC) - A case series. |
|---|---|
| Authors: | Rausch C; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich. Electronic address: Christian.Rausch@med.uni-muenchen.de., Schwicht C; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich., Doedens D; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich., Forstpointner R; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich., Westphalen CB; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich., Heinemann V; Medizinische Klinik und Poliklinik III, Campus Grosshadern, LMU Klinikum Munich. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Oct; Vol. 174, pp. 37-39. Date of Electronic Publication: 2022 Aug 12. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
